Enasidenib has 3 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Rosuvastatin, Rosuvastatin Calcium. Patients taking Enasidenib should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Major
- 2
Major (2)
- Enasidenib + Rosuvastatin— Enasidenib increased rosuvastatin exposure more than 2.4-fold, increasing the risk of myopathy and rhabdomyolysis. Do no…
- Enasidenib + Rosuvastatin Calcium— Enasidenib increases rosuvastatin exposure more than 2.4-fold, increasing risk of myopathy and rhabdomyolysis. Do not ex…